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Abstract
Background: To improve the quality of antimicrobial stewardship (AMS) interventions the application of
behavioural sciences supported by multidisciplinary collaboration has been recommended. We analysed major
UK scientific research conferences to investigate AMS behaviour change intervention reporting.
Methods: Leading UK 2015 scientific conference abstracts for 30 clinical specialties were identified and interrogated.
All AMS and/or antimicrobial resistance(AMR) abstracts were identified using validated search criteria. Abstracts were
independently reviewed by four researchers with reported behavioural interventions classified using a behaviour
change taxonomy.
Results: Conferences ran for 110 days with >57,000 delegates. 311/12,313(2.5%) AMS-AMR abstracts (oral and poster)
were identified. 118/311(40%) were presented at the UK’s infectious diseases/microbiology conference. 56/311(18%)
AMS-AMR abstracts described behaviour change interventions. These were identified across 12/30(40%) conferences.
The commonest abstract reporting behaviour change interventions were quality improvement projects [44/56 (79%)].
In total 71 unique behaviour change functions were identified. Policy categories; “guidelines” (16/71) and “service
provision” (11/71) were the most frequently reported. Intervention functions; “education” (6/71), “persuasion” (7/71),
and “enablement” (9/71) were also common. Only infection and primary care conferences reported studies that
contained multiple behaviour change interventions. The remaining 10 specialties tended to report a narrow range of
interventions focusing on “guidelines” and “enablement”.
Conclusion: Despite the benefits of behaviour change interventions on antimicrobial prescribing, very few AMS-AMR
studies reported implementing them in 2015. AMS interventions must focus on promoting behaviour change towards
antimicrobial prescribing. Greater focus must be placed on non-infection specialties to engage with the issue of
behaviour change towards antimicrobial use.
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Background
In the United Kingdom (UK), about one third of all
hospital inpatients receive antimicrobials during their
admission with a significant proportion of these iden-
tified as inappropriate [1–3]. This accounts for a large
amount of unnecessary antimicrobial exposure. Anti-
microbial resistance (AMR) is a leading patient safety
issue that requires urgent interventions to curb its
exponential growth. One target of interventions to
address the problem of AMR is the promotion of the
appropriate use of antimicrobials in humans, which is
thought to be a leading driver for the growth of
AMR [4].
To address this and promote the appropriate use of
antimicrobial agents a number of national and inter-
national antimicrobial stewardship (AMS) initiatives
have been implemented [5–8]. A key facet of these
interventions targets improving and sustaining indi-
vidual prescribing behaviours. Implementation of
AMS programmes have been demonstrated to reduce
rates of AMR and improve health and economic out-
comes [9–11]. However, despite these positive steps
forward, several challenges appear to remain in pro-
moting the sustainable use of antimicrobials across
clinical practice [12].
Firstly, there is a growing body of evidence to
describe the cultural and social factors that influence
antimicrobial prescribing across healthcare settings
as well as qualitative data that supports the role of
behaviour change interventions in improving anti-
microbial prescribing [13–16]. Despite this, very little
evidence exists to describe the current landscape of
behaviour change interventions being implemented
within this field [12, 13, 15–20]. Secondly, despite
evidence to support engagement of infection special-
ists with the AMS-AMR agenda, there appears to be
poorer engagement across other clinical specialties in
terms of formal training and awareness at state-of-the-
art scientific conferences [21–23]. Finally, although
there are described frameworks and taxonomy’s avail-
able from which to begin mapping behaviour change
methods [24, 25], very little data is currently available
to describe the appropriateness of these specifically for
AMS interventions.
In this cross-sectional study we aimed to explore
antimicrobial stewardship interventions reported at
major cross specialty UK state-of-the-art scientific
conferences in 2015, which contained behaviour
change interventions. We aimed to determine the
number and type of behaviour change interventions
reported by different specialties and compare these to
currently available behaviour change taxonomies to
identify potential gaps and highlight potential targets
for future interventions.
Methods
Abstract identification & screening
All major medical specialties recognised by the Royal
College of Physicians, London, UK, were identified and in-
cluded alongside major surgical specialties identified by the
intercollegiate surgical curriculum programme. Psychiatric,
paediatric, and obstetrics and gynaecology specialties were
also included. UK specialists (specialist trainees or consul-
tants) in each of the defined fields were consulted by email
to determine the largest clinical scientific/research confer-
ence within the UK in 2015. Two specialists from each
field, who were based in the North West London area were
contacted for their opinions. Where there was disagree-
ment, the authors opted for the conference with the largest
attendance. Educational, continuing professional develop-
ment and sub-specialty conferences were not considered
for inclusion given their often focused agendas, which may
have biased our findings.
Each major conference per specialty was identified and
abstract booklets extracted and interrogated. Conference
characteristics collated included; location, conference
dates, estimated attendance and total number of ab-
stracts accepted (either as oral, poster or publication
only). Accepted conference abstracts (invited, oral, pos-
ter and publication only) were then identified and inter-
rogated using a previously validated search criterion to
identify all abstracts relating to AMS and AMR. [21, 22]
All identified oral, poster, or published only abstracts
from the search were then anonymously reviewed by
two out of three authors (TMR, AMT, & AT). Abstracts
were included if they were deemed to be describing an
aspect of AMS [26] or AMR [27] in terms of direct ef-
fect on patients. In vitro studies with no translational
benefit to individual patients were excluded. For the
purpose of our investigation we focused on bacterial re-
sistance and stewardship, abstracts relating solely to
antiviral, antifungal, antiprotozoal or antimycobacterial
resistance were excluded. This focus was selected given
that anti-bacterial agents make up over 93% of all
antimicrobials prescribed for systemic use [28]. Further-
more, the large variation in prescribing of other anti-
microbial classes across different specialties may have
influenced our results. When there was disparity be-
tween the opinions of reviewers’ a fourth independent
reviewer (LSPM) was consulted to reach consensus.
Characterising behaviour change interventions
Once all AMS-AMR abstracts had been identified the
rates of AMS-AMR coverage between specialty confer-
ences was assessed. Abstracts were then re-read by at
least two of four researchers (TMR, AMT, AT, & LSPM)
and categorised into types of intervention reported in
the abstracts. To categorise the types of interventions re-
ported a modified version of intervention and policy
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framework definitions provided by Michie and col-
leagues for the construction of their behaviour change
wheel were used (Additional file 1: Table S1) [25]. In the
original behaviour change wheel, three layers (policy,
intervention, and behaviour systems are described).
Within the classification used in this study, behaviour
systems were not included (capability, opportunity,
motivation, and behaviour; COM-B) as reported inter-
ventions were focused on the two levels of the frame-
work above this, which aim to directly influence COM-B
[25]. Researchers attempted, where possible, to categor-
ise reported behaviour change interventions into one or
more of the sixteen functions (split into policies and in-
terventions) described within this framework. Although
the framework is designed to provide flexibility and ac-
commodate multiple interventions/policy combinations,
researchers attempted to strictly categorise reported
interventions into the fewest number of categories pos-
sible. When there was discrepancy the group discussed
these issues until consensus was reached. Descriptive
statistics was performed in SPSS 22.0 (IBM, Chicago, IL)
with Chi-squared with Yates correction. Ethics approval
was not required for this observational study.
Results
AMS-AMR coverage at UK state-of-the-art scientific
conferences in 2015
Thirty specialty state-of-the-art scientific conferences ab-
stract booklets were identified and extracted for analysis.
These conferences ran over >110 days with >57,000 dele-
gates estimated to of attended them in 2015 (Table 1). In
total, 12,313 abstracts were extracted for analysis with 311
Table 1 UK state-of-the-art scientific conference summary
Speciality City Date commenced No Days No delegates No abstracts accepted
Anaesthetics [44] Edinburgh 23/09/2015 3 800 161
Breast Surgery [45] Bournemouth 15/06/2015 2 870 221
Cardiology [46] Manchester 08/06/2015 3 2448 235
Dermatology [47] Manchester 06/07/2015 4 1200 372
Emergency Medicine [34] Manchester 28/09/2015 3 650 69
Endocrinology [37] Edinburgh 02/11/2015 3 1000 526
Gastroenterology [48] London 22/06/2015 4 4500 1240
Primary Care [38] Glasgow 01/10/2015 3 1600 450
General Surgery [49] Manchester 22/04/2015 3 1500 1065
Surgery (ASiT) [50] Glasgow 27/02/2015 3 700 602
Genitourinary Medicine [30] Glasgow 01/06/2015 3 500 299
Geriatrics [36] Brighton 14/10/2015 3 500 76
Haematology [51] Edinburgh 20/04/2015 3 1000 257
Infection/Microbiology [29] Glasgow 21/11/2015 3 1000 375
Intensive Care [52] London 07/12/2015 3 1250 154
Nephrology [43] London 28/05/2015 4 8190 1945
Neuro surgery [53] York 09/09/2015 3 200 139
Neurology [33] Harrogate 20/05/2015 3 600 194
Obstetrics & Gynaecology [54] Brisbane 12/04/2015 4 2300 770
Ophthalmology [55] Liverpool 18/05/2015 4 1700 228
Orthopaedics [31] Liverpool 15/09/2015 4 1600 96
Paediatric surgery [56] Cardiff 22/07/2015 3 346 83
Paediatrics [57] Birmingham 28/04/2015 3 2000 546
Plastic surgery [32] Birmingham 25/11/2015 3 400 78
Psychiatry [35] Birmingham 29/06/2015 4 2500 79
Respiratory [58] London 02/12/2015 3 2200 460
Rheumatology [59] Manchester 28/04/2015 3 2000 677
Transplant surgery [60] Bournemouth 11/03/2015 3 700 382
Urology [61] Manchester 15/06/2015 4 1200 161
Vascular surgery [62] Bournemouth 11/11/2015 3 800 373
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(2.5%) identified as related to AMS-AMR (Fig. 1). Of
these, 118/311 (38%) were presented at the UK’s infectious
diseases/microbiology conference [29]. This made up 38%
(144/375) of all conference abstracts reported at this con-
ference. Genitourinary medicine [30] had the second high-
est coverage with 9% (26/299), orthopaedics [31] third and
plastic surgery [32] fourth with 8% of abstracts related to
AMS-AMR each (8/96 & 6/78, respectively). All other
specialty’s had <5% AMS-AMR coverage with neurology
[33], emergency medicine [34], psychiatry [35], geriatrics
[36], and endocrinology [37] not having any AMS-AMR
related coverage at their 2015 conferences. Compared to
published data on conference coverage in the UK in 2014
[21] there was no significant difference in the level of
AMS-AMR reporting (311/12,313, 2.5%, in 2015 & 221/
7843, 2.8%, in 2014; p = 0.22). Infection/microbiology had
a significantly larger proportion of AMS-AMR abstracts
compared to all other specialties reviewed within this
study (p < 0.01).
Reported behaviour change interventions for
antimicrobial prescribing
Of the 311 AMS-AMR abstracts identified 56 (18%) de-
scribed behaviour change interventions (Table 2). Of
these, 28/56 (50%) were reported at the infection/micro-
biology conference with general surgery conferences
reporting the second largest proportion with 7/56 (13%).
In total, behaviour change interventions were reported
across 12/30 (40%) specialty state-of-the-art conferences
with infection/microbiology reporting a significantly
greater amount that all other conferences (p < 0.01). The
commonest abstracts reporting behaviour change inter-
ventions were quality improvement projects accounting
for 44/56 (79%) of all reported behaviour change inter-
ventions. However, this represented a minority of all
AMS-AMR quality improvement projects identified with
80/124 (65%) either not reporting any intervention or
not reporting a specific behaviour change intervention.
The remainder of behaviour change interventions in-
cluded were found to be reported within observational
studies (12/56; 21%). This also represented a minority of
observational studies reporting AMS-AMR topics across
clinical specialties (12/54; 22%).
In total, 71 unique behaviour change functions were
identified across the 56 abstracts reported behaviour
change interventions (Table 2). Eight abstracts were
deemed to describe multiple behaviour change interven-
tions with six of these being reported at the infectious
diseases/microbiology conference [29] and two at the
primary care conference [38]. Policy categories; “guide-
lines” (16/71) and “service provision” (11/71) were the
most frequently reported. Intervention functions; “edu-
cation” (6/71), “persuasion” (7/71), “enablement” (9/71),
and environmental restructuring (9/71) were also com-
mon. Intervention categories “incentivisation” and “coer-
cion” and policy categories “fiscal” and “legislation” were
not reported in any interventions. However, only infec-
tion/microbiology and primary care tended to report a
broad variety of interventions, with the majority of inter-
ventions reported in the remaining ten specialties tend-
ing to focus on enablement (intervention) and guidelines
or service provision (policy). The types of functions
reported in abstracts that described multiple behaviour
change interventions (8/56; 14%) are highlighted in
Table 3. In abstracts reporting multiple behaviour
change intervention functions there was a mix of policy
and intervention targets with guidelines featuring in 6/8
(75%), environmental restructuring, education and per-
suasion all featuring in 4/8 (50%), and service provision
in 3/8 (38%) of the abstracts.
Discussion
Clinical state-of-the-art conferences provide an oppor-
tunity for medical professionals to participate in research
and reporting. They also allow us to gain an insight into
different levels of research being undertaken within the
field; from small scale research undertaken at the local
level, to large scale studies being performed by key
opinion leaders and organisations. This provides a
window into the activities within specialties that is less
influenced by publication bias than can often be ob-
served through systematically reviewing peer-reviewed
Fig. 1 Selection method to identify antimicrobial stewardship/
antimicrobial resistance abstracts among state-of-the-art
conferences in 2015
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publications. Within this study, we observed a low rate
of behaviour change intervention reporting across the
majority of specialty state-of-the-art conferences in
2015. Infection specialties reported a significantly greater
number and broader variety of AMS-AMR interventions
with the majority of interventions reported by non-
infection specialties falling into a narrow band of inter-
vention and policy based functions.
These observations are concerning given the recent
focus placed upon the need for cross-specialty engage-
ment with AMS-AMR and behaviour change interven-
tions. This has been supported broadly in the literature
[4, 13, 16, 21, 22, 39]; by national organisations including
Public Health England (PHE) [18], the British Society for
Antimicrobial Chemotherapy (BSAC), and government
[40]; and major international governments and organisa-
tions [6, 7]. These findings highlight the need to broaden
the focus of AMS campaigns beyond infection specialties
to promote leadership from within cohorts, which can
drive behaviour change towards antimicrobial use.
This must be supported by clear and defined tools to
help specialties engage and design AMS-AMR behaviour
change interventions and assess the impact of these on pa-
tient outcomes. Whilst the use of behaviour change taxon-
omies allows content of interventions to be coded and
categorised, facilitating the analysis of behaviour change
interventions [24, 41], they are not appropriate for deter-
mining the effectiveness of interventions. Furthermore, for
the field of AMS-AMR there remains no definition on
what an appropriate behaviour change intervention is.
This makes evaluating behaviour change challenging as
certain functions of any framework used may be irrelevant
or actually have a negative impact on behaviours within
this context. [24, 41, 42] Kok and colleagues argue that as
behavioural determinants are often specific to behaviours,
populations, and contexts characterisations should thus
be individualised and tailored for such [24, 41]. This will
require engagement and drive from within clinical special-
ties to review current practices, define the context in
which AMS-AMR interventions need to be implemented,
and then tailor behaviour change interventions to opti-
mise their effect within their local environment.
Finally, in a previous study “high risk” specialties were
identified that currently use large amounts of antimicro-
bials and also experience high levels of healthcare associ-
ated infections [21]. This study reported that certain
“high risk” specialties such as infection and intensive
care had relatively high levels of engagement with AMS-
AMR, whilst other specialties such as haematology and
nephology tended to have a low apparent engagement at
scientific conferences [21]. Within this study, we have
observed an overall low rate of behaviour change
interventions across all high risk specialties reported
previously with only infection [29] and nephrology [43]
reporting any behaviour change interventions in 2015.
Furthermore, specialties with relatively high coverage of
AMS-AMR at scientific conferences, such as Genitouri-
nary Medicine, failed to report on behaviour change in-
terventions despite having 9% coverage of AMS-AMR
topics in 2015. This highlights the need for greater pan-
specialty promotion of behaviour change interventions
for AMS-AMR given the significant lack of focus on
reporting such interventions currently.
There are several limitations to this study. Firstly, we
only selected one leading state-of-the-art conference for
each major clinical specialty in the UK. This makes our
findings difficult to generalise across other countries and
also may have introduced bias through excluding smaller,
conferences and meetings, where specialties may have had
more of an AMS-AMR focus. However, this method was
selected as we aimed to generate a representative picture
of current behaviour change interventions and the import-
ance placed upon this by different specialties. By selecting
leading state-of-the-art conferences we hoped that this
would reflect the current overall importance of this subject
within the specialty as well as allow for a more representa-
tive view of work being undertaken in the field. Secondly,
we did not review invited talks and seminars provided by
conferences given that they often were not presenting
original data or results. Furthermore, as the taxonomy
used to describe behaviour change does not allow for
evaluation of the effectiveness of interventions it is not
possible to evaluate whether interventions described were
“appropriate” for the context in which they were described.
Finally, as only a relatively small number of specialists from
a specific geographical area were contacted to seek opinions
on defining the largest UK conference in their field this
may have introduced bias in our conference selection. To
address this we ensured that two specialists from each field
were contacted for their opinions. When there was discrep-
ancy in responses from the individuals, conference attend-
ance size was considered as the determinant with the
conference with the largest attendance selected.
Table 3 Outline of intervention functions reported in abstracts
reporting multiple behaviour change interventions
Primary Care 1. Guideline, persuasion, & modelling
2. Education, persuasion & environmental
restructuring
Infection/Microbiology 3. Guideline, persuasion & environmental
4. Guideline, persuasion & service provision
5. Guideline, environmental restructuring,
education, communication
6. Guideline, education, service provision,
environmental restructure
7. Guideline & service provision
8. Education & environmental restructuring
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Conclusion
In conclusion, despite evidence to support the role of
behaviour change interventions for improving antimicro-
bial prescribing, very few studies reported implementing
them at UK state-of-the-art conferences in 2015. Future
research must focus on providing appropriate frame-
works and mechanisms to allow clinical specialties to
engage with AMS-AMR and design and evaluate the
impact of behaviour change interventions within their
specific contexts.
Additional file
Additional file 1: Table S1. Behaviour change taxonomy used for
classification of interventions reported in state-of-the-art scientific conference
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